MidCap Financial is a middle-market-focused specialty finance firm providing senior debt and direct lending solutions to companies across all industries. Founded in 2008 and acquired by Apollo Global Management, it now serves as Apollo's primary middle-market direct origination platform, managing approximately $51 billion in commitments.
38% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $56.7M (across 7 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Aaron Arnold
Managing Director
Bradley Kastner
Managing Director
John O'Brien
Managing Director
Joshua Rothenberg
Managing Director
TJ Ceravolo
Managing Director
Bryson Stirewalt
Director
Jason Pomeroy
Director
Luba Morgan
Director
David Crescenzi
Co-Head Financial Sponsors & Leveraged Finance
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Carbon6 | Series A | $66M | Oct 2022 |
| Carbon6 | Series A | $75M | Jan 2022 |
 UPSTACK | Unknown | $50M | Apr 2021 |
 Sight Sciences | Series F | — | Dec 2020 |
 Partner Therapeutics | Series A | $60M | Feb 2018 |
 DNAnexus | Series C | $58M | Jan 2018 |
 BioDelivery Sciences International, Inc. | Unknown | $30M | — |
| DNAnexus | Series E | $58M | — |
Top Co-Investors
Last updated: 27 September 2026